相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
Alexandra Schafer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques (vol 586, pg 583, 2020)
Noe B. Mercado et al.
NATURE (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler et al.
CELL (2021)
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
Jie Hu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
Robert J. Fischer et al.
NATURE COMMUNICATIONS (2021)
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara et al.
CELL (2021)
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
Hannah A. D. King et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Donata Hoffmann et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Army Liposome Formulation (ALF) family of vaccine adjuvants
Carl R. Alving et al.
EXPERT REVIEW OF VACCINES (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Animal models for COVID-19
Cesar Munoz-Fontela et al.
NATURE (2020)
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
Lisa H. Tostanoski et al.
NATURE MEDICINE (2020)
Direct visualization of translational GTPase factor pool formed around the archaeal ribosomal P-stalk by high-speed AFM
Hirotatsu Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)